- Tytuł:
- Chemoimmunotherapy Versus Pembrolizumab as a First-Line Treatment for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Focus on the Role of Performance Status
- Autorzy:
- Źródło:
- Targeted Oncology. 18(6):915-925
Czasopismo naukowe